In America and Europe, the most common malignant tumor of the eyelid is basal cell carcinoma (BCC), accounting for 80–95% of all eyelid malignancies. SGC is associated with poorer prognosis compared to other eyelid malignant tumors. Conclusion: In Asian Indians, SGC is twice as common as BCC and 3 times more common than SCC. 16, < 1, and 8% p = 0.001) over a mean follow-up period of 19 months. Compared to SGC, BCC, and SCC, locoregional lymph node metastasis was more common with miscellaneous tumors (26 vs. Comparing SGC with BCC, SCC, and miscellaneous tumors, SGC was more commonly associated with tumor recurrence (21 vs. The clinicopathological correlation of SGC, BCC, SCC, and miscellaneous tumors was 91, 86, 46, and 38% ( p = 0.001), respectively. The statistically significant differences between eyelid malignant tumors included age at presentation, tumor location, and tumor extent. Histopathology-proven diagnoses of these patients included sebaceous gland carcinoma (SGC) ( n = 285, 53%), basal cell carcinoma (BCC) ( n = 128, 24%), squamous cell carcinoma (SCC) ( n = 99, 18%), and miscellaneous tumors ( n = 24, 4%). Results: The mean age at presentation with eyelid malignancy was 58 years.
Methods: This is a retrospective study of 536 patients. Purpose: To study the proportion of eyelid malignant tumors in an Asian Indian population and to review their clinical features and outcomes.
0 kommentar(er)
